My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    Prevalence of antiplatelet therapy in patients with diabetes.

    Miller SR, Littenberg B, MacLean CD.

    Cardiovasc Diabetol. 2005 Dec 1;4:18.PMID: 16321162 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    2.

    Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.

    Bulatova NR, Yousef AM, AbuRuz SM.

    Thromb Res. 2007;121(1):43-50. Epub 2007 Apr 25.PMID: 17462716 [PubMed - indexed for MEDLINE]Related citations

    3.

    Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada.

    Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR.

    Clin Ther. 2004 Mar;26(3):439-46.PMID: 15110137 [PubMed - indexed for MEDLINE]Related citations

    4.

    High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

    Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM.

    Diabetes Care. 2006 Apr;29(4):798-804.PMID: 16567818 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    5.

    Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.

    Bruno A, Grassi G, Dani F, Degiovanni M, Maghenzani G, Pagano G.

    Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):42-6.PMID: 15871850 [PubMed - indexed for MEDLINE]Related citations

    6.

    Influence of cardiovascular disease risk factors on the relationship between low bone mineral density and type 2 diabetes mellitus in a multiethnic US population of women and men: a cross-sectional study.

    Broussard DL, Magnus JH.

    Gend Med. 2008 Sep;5(3):229-38.PMID: 18727989 [PubMed - indexed for MEDLINE]Related citations

    7.

    Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.

    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.

    Clin Ther. 2008 Feb;30(2):249-59.PMID: 18343263 [PubMed - indexed for MEDLINE]Related citations

    8.

    A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

    Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

    Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related citations

    9.

    Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service.

    Johnson SG, Witt DM, Eddy TR, Delate T.

    Chest. 2007 May;131(5):1500-7.PMID: 17494799 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    10.

    [HDL cholesterol and cardiovascular disease in a population with hypertension and type 2 diabetes mellitus. RICARHD Study]

    Conthe P, Gómez-Fernández P, de Alvaro F, Fernández-Pérez C, González-Esteban J, Cea-Calvo L; Investigadores del estudio RICARHD.

    Rev Clin Esp. 2009 May;209(5):227-33. Spanish. PMID: 19480779 [PubMed - indexed for MEDLINE]Related citations

    11.

    Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.

    Price HC, Coleman RL, Stevens RJ, Holman RR.

    Diabetologia. 2009 Mar;52(3):394-7. Epub 2008 Dec 2.PMID: 19048226 [PubMed - indexed for MEDLINE]Related citations

    12.

    An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.

    Holmes CE, Ramos-Nino ME, Littenberg B.

    BMC Cancer. 2010 Jun 15;10:289.PMID: 20546622 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    13.

    The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age.

    Cleveringa FG, Meulenberg MG, Gorter KJ, van den Donk M, Rutten GE.

    J Diabetes Complications. 2009 May-Jun;23(3):153-9. Epub 2008 Apr 16.PMID: 18413203 [PubMed - indexed for MEDLINE]Related citations

    14.

    Antiplatelet therapy in type 2 diabetes mellitus.

    Angiolillo DJ.

    Curr Opin Endocrinol Diabetes Obes. 2007 Apr;14(2):124-31. Review.PMID: 17940430 [PubMed - indexed for MEDLINE]Related citations

    15.

    [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]

    Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider HJ, Lehnert H, Böhler S, Koch U, Wittchen HU.

    Med Klin (Munich). 2006 Aug 15;101(8):635-44. German. PMID: 16896570 [PubMed - indexed for MEDLINE]Related citations

    16.

    Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.

    Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM; TRITON-TIMI 38 Investigators.

    Circulation. 2008 Oct 14;118(16):1626-36. Epub 2008 Aug 31.PMID: 18757948 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    17.

    Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

    Lee HY, Cooke CE, Robertson TA.

    J Manag Care Pharm. 2008 Apr;14(3):271-80.PMID: 18439049 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    18.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related citations

    19.

    Changing aspirin use in patients with Type 2 diabetes in the UKPDS.

    Cull CA, Neil HA, Holman RR.

    Diabet Med. 2004 Dec;21(12):1368-71.PMID: 15569143 [PubMed - indexed for MEDLINE]Related citations

    20.

    Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.

    Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K, Shofer JB, Heckbert SR, Boyko EJ, Fujimoto WY, Kahn SE.

    Diabetes Care. 2006 Sep;29(9):2078-83.PMID: 16936156 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk